Your Markets. Our Intelligence.

Entering a new market in sub-Saharan Africa or South Asia without reliable intelligence is how manufacturers make expensive mistakes — overestimating demand, mispricing for the market, or choosing the wrong distribution model for the health system context. By the time a bespoke analysis is commissioned, assembled, and presented to leadership, the market has shifted and the window has narrowed.

Merlyn AI gives manufacturers what no commercial data provider currently offers: robust market intelligence based on real order and pricing data across both public and private channels, assembled in one place and updated continuously.

What you can do with Merlyn:

• Build your launch strategy — business model, manufacturing approach, priority market sequencing, and fair pricing tiers, modelled against real market data and benchmarked against comparable products

• Forecast demand with confidence — ProductDNA identifies the closest historical analogues for your product across five dimensions simultaneously, generating probabilistic uptake curves and 20-year demand projections with confidence intervals

• Develop a defensible pricing strategy — ElasticIQ models fair pricing tiers across public and private channels, accounting for disease burden, ability to pay, reimbursement status, and price referencing risk

• Build the business case your leadership will approve — 10-year revenue projections across bull, base, and bear scenarios, with gross margin, patients reached, and health system savings in one dashboard

• Defend your market presence over time — for companies already operating in LMICs, Merlyn helps you optimize pricing, track market dynamics, and make the internal case for staying in markets where the long-term strategic value outweighs short-term P&L pressure
  
  

Finally see the markets you have been trying to enter.